What is NDC 50268-491?

50268-491 is the product NDC for Lacosamide, Lacosamide 50 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.

AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lacosamide?

146 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lacosamide NDC 50268-491 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50268-491Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50268-0491Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50268-491-10	50268049110	100 BLISTER PACK in 1 BOX (50268-491-10) / 1 TABLET in 1 BLISTER PACK (50268-491-11)Marketed from Sep 29, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lacosamide
Generic name (nonproprietary): lacosamide
Active ingredients: Lacosamide — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: AvPAKNDC labeler code 50268
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208308
Marketing start: Sep 29, 2026
Listing expires: Dec 31, 2027
DEA schedule: CV
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 50268-491_5ca5b051-08b7-2b4d-e063-6294a90a144bSPL ID 5ca5b051-08b7-2b4d-e063-6294a90a144b

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450268049110 followed by a unit qualifier and the quantity

Package 50268-0491-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 50268-491

What is NDC 50268-491?: 50268-491 is the product NDC for Lacosamide, Lacosamide 50 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lacosamide.
What is the active ingredient?: Lacosamide.
Who is the labeler?: AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lacosamide?: 146 other product NDCs are listed under this name. See all Lacosamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lacosamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lacosamide	Lacosamide 100 mg/1	TabletOral	AvPAK	50268-492	50268-0492-10
Lacosamide	Lacosamide 50 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4689	70518-4689-0070518-4689-0270518-4689-03
Lacosamide	Lacosamide 10 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-697	68462-0697-30
Lacosamide	Lacosamide 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4561	70518-4561-0070518-4561-02
Lacosamide	Lacosamide 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4562	70518-4562-00
Lacosamide	Lacosamide 10 mg/mL	Injection, SolutionIntravenous	Anthea Pharma Private Limited	83854-002	83854-0002-10
Lacosamide	Lacosamide 50 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4503	70518-4503-00
Lacosamide	Lacosamide 200 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4504	70518-4504-0070518-4504-0170518-4504-03
Lacosamide	Lacosamide 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4505	70518-4505-00
Lacosamide	Lacosamide 50 mg/5mL	SolutionOral	Precision Dose, Inc.	68094-076	68094-0076-62

All 147 Lacosamide NDCs

Other NDCs under ANDA 208308

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208308
Product	Strength	Form · route	Labeler	Product NDC
Lacosamide	Lacosamide 50 mg/1	TabletOral	Indoco Remedies Limited	14445-129
Lacosamide	Lacosamide 100 mg/1	TabletOral	Indoco Remedies Limited	14445-130
Lacosamide	Lacosamide 150 mg/1	TabletOral	Indoco Remedies Limited	14445-131
Lacosamide	Lacosamide 200 mg/1	TabletOral	Indoco Remedies Limited	14445-132
Lacosamide	Lacosamide 50 mg/1	TabletOral	NorthStar RxLLC	16714-548
Lacosamide	Lacosamide 100 mg/1	TabletOral	NorthStar RxLLC	16714-549
Lacosamide	Lacosamide 150 mg/1	TabletOral	NorthStar RxLLC	16714-550
Lacosamide	Lacosamide 200 mg/1	TabletOral	NorthStar RxLLC	16714-552
Lacosamide	Lacosamide 50 mg/1	TabletOral	Tris Pharma Inc	27808-243
Lacosamide	Lacosamide 100 mg/1	TabletOral	Tris Pharma Inc	27808-244
Lacosamide	Lacosamide 150 mg/1	TabletOral	Tris Pharma Inc	27808-245
Lacosamide	Lacosamide 200 mg/1	TabletOral	Tris Pharma Inc	27808-246
Lacosamide	Lacosamide 100 mg/1	TabletOral	AvPAK	50268-492
Lacosamide	Lacosamide 50 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-220
Lacosamide	Lacosamide 100 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-221
Lacosamide	Lacosamide 150 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-222
Lacosamide	Lacosamide 200 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-223